高级检索
当前位置: 首页 > 详情页

Zuogui Wan improves spermatogenesis of GC1-spg cells through modulating AR-related pathways

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Graduate School of Beijing University of Chinese Medicine, Beijing, China [2]Andrology Department, China-Japan Friendship Hospital, Beijing, China [3]Department of Andrology, Shunyi Hospital of Beijing Traditional Chinese medicine hospital, Beijing, China [4]Andrology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
出处:
ISSN:

关键词: apoptosis GC1-spg cells infertility proliferation Zuogui Wan

摘要:
Zuogui Wan (ZGW) is a common prescription medication used in traditional Chinese medicine (TCM) to significantly improve the sperm quality and treat male infertility. This study evaluated the repair effect of ZGW and Levocarnitine (LEV) on GC1-spg cell injury induced by Glucosides of Tripterygium WilforDII Hook (GTW). The results showed that the ultrastructure and apoptosis rate of GC1- spg cells in LEV and ZGW group were considerably better than GTW. The transcriptional and translational level of CYP1A1, CYP17A1, androgen receptor (AR), SRD5A2 and proliferating cell nuclear antigen (PCNA) in GC-1spg cells of the LEV group were considerably elevated than GTW group (p < 0.05 or 0.01). Furthermore, the transcriptional and translational levels of CYP19A1, CYP17A1, AR, SRD5A2 and PCNA in GC-1spg cells in ZGW group were found to be considerably elevated than the LEV group (p < 0.05 or 0.01). The findings indicate that ZGW and LEV could increase the expression of PCNA, CYP17A1, CYP19A1, SRD5A2 and AR at transcriptional and translational levels, inhibit GC-1spg cell apoptosis and promoting cell proliferation, and the effect of ZGW was found to be significantly better than that of LEV.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 3 区 男科学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 男科学
JCR分区:
出版当年[2020]版:
Q3 ANDROLOGY
最新[2023]版:
Q3 ANDROLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Graduate School of Beijing University of Chinese Medicine, Beijing, China [2]Andrology Department, China-Japan Friendship Hospital, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [4]Andrology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China [*1]Department of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)